Literature DB >> 9438742

Human cardiovascular and metabolic response to acute, severe isovolemic anemia.

R B Weiskopf1, M K Viele, J Feiner, S Kelley, J Lieberman, M Noorani, J M Leung, D M Fisher, W R Murray, P Toy, M A Moore.   

Abstract

CONTEXT: Although concern over the risks of red blood cell transfusion has resulted in several practice guidelines for transfusion, lack of data regarding the physiological effects of anemia in humans has caused uncertainty regarding the blood hemoglobin (Hb) concentration requiring treatment.
OBJECTIVE: To test the hypothesis that acute isovolemic reduction of blood Hb concentration to 50 g/L in healthy resting humans would produce inadequate cardiovascular compensation and result in tissue hypoxia secondary to inadequate oxygen transport.
DESIGN: Before and after interventional study.
SETTING: Academic tertiary care medical center. PARTICIPANTS: Conscious healthy patients (n =11) prior to anesthesia and surgery and volunteers not undergoing surgery (n=21).
INTERVENTIONS: Aliquots of blood (450-900 mL) were removed to reduce blood Hb concentration from 131 (2) g/L to 50 (1) g/L [mean (SE)]. Isovolemia was maintained with 5% human albumin and/or autologous plasma. Cardiovascular parameters, arterial and mixed venous oxygen content, oxyhemoglobin saturation, and arterial blood lactate were measured before and after removal of each aliquot of blood. Electrocardiogram and, in a subset, Holter monitor were monitored continuously. MAIN OUTCOME MEASURES: "Critical" oxygen delivery (TO2) as assessed by oxygen consumption (VO2), plasma lactate concentration, and ST changes on electrocardiogram.
RESULTS: Acute, isovolemic reduction of Hb concentration decreased systemic vascular resistance and TO2 and increased heart rate, stroke volume, and cardiac index (each P<.001). We did not find evidence of inadequate oxygenation: VO2 increased slightly from a mean (SD) of 3.07 (0.44) mL of oxygen per kilogram per minute (mL O2 x kg(-1) x min[-1]) to 3.42 (0.54) mL O2 x kg(-1) x min(-1) (P<.001) and plasma lactate concentration did not change (0.81 [0.11] mmol/L to 0.62 [0.19] mmol/L; P=.09). Two subjects developed significant ST changes on Holter monitor: one apparently related to body position or activity, the other to an increase in heart rate (at an Hb concentration of 46-53 g/L); both occurred in young women and resolved without sequelae.
CONCLUSIONS: Acute isovolemic reduction of blood Hb concentration to 50 g/L in conscious healthy resting humans does not produce evidence of inadequate systemic TO2, as assessed by lack of change of VO2 and plasma lactate concentration. Analysis of Holter readings suggests that at this Hb concentration in this resting healthy population, myocardial ischemia would occur infrequently.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9438742     DOI: 10.1001/jama.279.3.217

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  81 in total

1.  Haematocrit and red blood cell transport in preterm infants: an observational study.

Authors:  P Pladys; A Beuchée; E Wodey; L Tison; P Bétrémieux
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-03       Impact factor: 5.747

2.  Evaluation of near infrared spectroscopy for detecting the β blocker-induced decrease in cerebral oxygenation during hemodilution in a swine model.

Authors:  Tadayoshi Kurita; Koji Morita; Shigehito Sato
Journal:  J Clin Monit Comput       Date:  2015-02-10       Impact factor: 2.502

Review 3.  Anemia in critical illness: insights into etiology, consequences, and management.

Authors:  Shailaja J Hayden; Tyler J Albert; Timothy R Watkins; Erik R Swenson
Journal:  Am J Respir Crit Care Med       Date:  2012-01-26       Impact factor: 21.405

Review 4.  Regulation of increased blood flow (hyperemia) to muscles during exercise: a hierarchy of competing physiological needs.

Authors:  Michael J Joyner; Darren P Casey
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

5.  A one-centre prospective audit of peri- and postoperative blood loss and transfusion practice in patients undergoing hip or knee replacement surgery.

Authors:  M Roberts; R Ahya; M Greaves; N Maffulli
Journal:  Ann R Coll Surg Engl       Date:  2000-01       Impact factor: 1.891

6.  Red Blood Cell Transfusion and Transfusion Alternatives in Traumatic Brain Injury.

Authors:  Andreas H Kramer; Peter Le Roux
Journal:  Curr Treat Options Neurol       Date:  2012-02-08       Impact factor: 3.598

7.  Risk and crisis management in intraoperative hemorrhage: Human factors in hemorrhagic critical events.

Authors:  Kazuo Irita
Journal:  Korean J Anesthesiol       Date:  2011-03-30

8.  Antiplatelet drugs: mechanisms and risks of bleeding following cardiac operations.

Authors:  Victor A Ferraris; Suellen P Ferraris; Sibu P Saha
Journal:  Int J Angiol       Date:  2011-03

Review 9.  Anemia of chronic disease: a harmful disorder or an adaptive, beneficial response?

Authors:  Ryan Zarychanski; Donald S Houston
Journal:  CMAJ       Date:  2008-08-12       Impact factor: 8.262

Review 10.  Management of the Jehovah's Witness in Obstetrics and Gynecology: A Comprehensive Medical, Ethical, and Legal Approach.

Authors:  Burak Zeybek; Andrew M Childress; Gokhan S Kilic; John Y Phelps; Luis D Pacheco; Michele A Carter; Mostafa A Borahay
Journal:  Obstet Gynecol Surv       Date:  2016-08       Impact factor: 2.347

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.